IdentificationGeneric Name(1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)AdenineDrugBank Accession NumberDB03216BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine (DB03216)× CloseWeightAverage: 233.2266 Monoisotopic: 233.091274621 Chemical FormulaC10H11N5O2SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUAdenosylhomocysteinaseNot AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as 1,3-substituted cyclopentyl purine nucleosides. These are nucleoside analogues with a structure that consists of a cyclobutane that is substituted a the 1-position with a hydroxyl group and at the 3-position with either a purine base.KingdomOrganic compoundsSuper ClassNucleosides, nucleotides, and analoguesClassNucleoside and nucleotide analoguesSub ClassCyclopentyl nucleosidesDirect Parent1,3-substituted cyclopentyl purine nucleosidesAlternative Parents6-aminopurines / Aminopyrimidines and derivatives / N-substituted imidazoles / Imidolactams / Heteroaromatic compounds / Secondary alcohols / 1,2-diols / Azacyclic compounds / Primary amines / Organopnictogen compounds / Hydrocarbon derivatives


 show 1 moreSubstituents1,2-diol / 1,3-substituted cyclopentyl purine nucleoside / 6-aminopurine / Alcohol / Amine / Aminopyrimidine / Aromatic heteropolycyclic compound / Azacycle / Azole / Heteroaromatic compound / Hydrocarbon derivative / Imidazole / Imidazopyrimidine / Imidolactam / N-substituted imidazole / Organic nitrogen compound / Organic oxygen compound / Organoheterocyclic compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Primary amine / Purine / Pyrimidine / Secondary alcohol


 show 15 moreMolecular FrameworkAromatic heteropolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyRQPALADHFYHEHK-CHKWXVPMSA-NInChIInChI=1S/C10H11N5O2/c11-9-7-10(13-3-12-9)15(4-14-7)5-1-2-6(16)8(5)17/h1-6,8,16-17H,(H2,11,12,13)/t5-,6+,8+/m1/s1IUPAC Name(1S,2S,5R)-5-(6-amino-9H-purin-9-yl)cyclopent-3-ene-1,2-diolSMILESNC1=NC=NC2=C1N=CN2[C@@H]1C=C[C@H](O)[C@H]1OReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound5287610PubChem Substance46505345ChemSpider4449940PDBe LigandADCPDB Entries1a7aClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility6.86 mg/mLALOGPSlogP-0.63ALOGPSlogP-1.2ChemaxonlogS-1.5ALOGPSpKa (Strongest Acidic)13.19ChemaxonpKa (Strongest Basic)4.1ChemaxonPhysiological Charge0ChemaxonHydrogen Acceptor Count6ChemaxonHydrogen Donor Count3ChemaxonPolar Surface Area110.08 Å2ChemaxonRotatable Bond Count1ChemaxonRefractivity61.44 m3·mol-1ChemaxonPolarizability22.43 Å3ChemaxonNumber of Rings3ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterNoChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9965Blood Brain Barrier+0.9207Caco-2 permeable-0.513P-glycoprotein substrateNon-substrate0.6781P-glycoprotein inhibitor INon-inhibitor0.9326P-glycoprotein inhibitor IINon-inhibitor0.7593Renal organic cation transporterNon-inhibitor0.9226CYP450 2C9 substrateNon-substrate0.8444CYP450 2D6 substrateNon-substrate0.8247CYP450 3A4 substrateNon-substrate0.6799CYP450 1A2 substrateNon-inhibitor0.8058CYP450 2C9 inhibitorNon-inhibitor0.8368CYP450 2D6 inhibitorNon-inhibitor0.8086CYP450 2C19 inhibitorNon-inhibitor0.6535CYP450 3A4 inhibitorNon-inhibitor0.9158CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.7592Ames testAMES toxic0.7172CarcinogenicityNon-carcinogens0.9193BiodegradationNot ready biodegradable0.9964Rat acute toxicity2.5712 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9502hERG inhibition (predictor II)Non-inhibitor0.8383  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn moreBinding Properties×PropertyMeasurementpHTemperature (°C)ReferencesIC 50 (nM)5830N/AN/AA30115IC 50 (nM)8700N/AN/AA30114Ki (nM)41N/AN/AA30113Ki (nM)49N/AN/AA30112


 Details


 Binding Properties1. AdenosylhomocysteinaseKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionNad bindingSpecific FunctionAdenosylhomocysteine is a competitive inhibitor of S-adenosyl-L-methionine-dependent methyl transferase reactions; therefore adenosylhomocysteinase may play a key role in the control of methylation...Gene NameAHCYUniprot IDP23526Uniprot NameAdenosylhomocysteinaseMolecular Weight47715.715 DaReferencesOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article] Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 